Acorah Software Products - Accounts Production 16.5.460 false true 31 March 2024 1 April 2023 false true No description of principal activity 1 April 2024 31 March 2025 31 March 2025 10120717 Mr Neil Sanders Mr Graham Sanders Mr Mark Rye iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10120717 2024-03-31 10120717 2025-03-31 10120717 2024-04-01 2025-03-31 10120717 frs-core:CurrentFinancialInstruments 2025-03-31 10120717 frs-core:Non-currentFinancialInstruments 2025-03-31 10120717 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10120717 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 10120717 frs-bus:Micro-entities 2024-04-01 2025-03-31 10120717 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10120717 frs-bus:Director1 2024-04-01 2025-03-31 10120717 frs-bus:Director2 2024-04-01 2025-03-31 10120717 frs-bus:Director3 2024-04-01 2025-03-31 10120717 2023-03-31 10120717 2024-03-31 10120717 2023-04-01 2024-03-31 10120717 frs-core:CurrentFinancialInstruments 2024-03-31 10120717 frs-core:Non-currentFinancialInstruments 2024-03-31
Registered number: 10120717
ELEVATE PHARMA LTD
Financial Statements
For The Year Ended 31 March 2025
Girlings & Co
Chartered Certified Accountants
11 High Street
Ruddington
Nottingham
NG11 6DT
Balance Sheet
Registered number: 10120717
2025 2024
£ £
Current assets 59,489 57,840
Creditors: Amounts Falling Due Within One Year (2,637 ) (963 )
NET CURRENT ASSETS 56,852 56,877
TOTAL ASSETS LESS CURRENT LIABILITIES 56,852 56,877
Creditors: Amounts Falling Due After More Than One Year (58,819 ) (52,267 )
Accruals and deferred income (1,890 ) (900 )
NET (LIABILITIES)/ASSETS (3,857 ) 3,710
CAPITAL AND RESERVES (3,857 ) 3,710

Notes

1. General Information
ELEVATE PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 10120717 . The registered office is 11 High Street, Ruddington, Nottingham, NG11 6DT.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
Page 0
Page 1
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Graham Sanders
Director
7th October 2025